Bristol Myers

0:09:05

Bristol-Myers CEO Says the Company Is in Transition

0:02:25

Bristol Myers Squibb stock rises following FDA approval of its schizophrenia drug

0:03:18

Bristol Myers Squibb - History and Company profile (overview)

0:02:13

Cramer's Mad Dash: Bristol Myers

1:04:09

Pfizer Aktie, Bristol Myers Squibb Aktie, Merck Aktie mit hoher Dividendenrendite

0:41:59

How Bristol Myers Squibb Optimises Its Global Manufacturing Network Strategy – Interview with Dan...

0:05:34

Bristol Myers Squibb CEO on cancer drug pipeline

0:01:37

Why is Bristol Myers Squibb blocking Americans from accessing more affordable generics?

0:01:55

BRISTOL-MYERS SQUIBB COMPANY STOCK ($BMY) : Review & Analysis (Price prediction, Dividend, News)

0:17:41

Bristol Myers Squibb | Global Patient Week 2023: LinkedIn Live

0:02:07

Feedback on schizophrenia treatment has been great, says Bristol Myers Squibb CEO

0:04:10

Trade Tracker: Jim Lebenthal sells Nike and Bristol-Myers, buys UnitedHealth

0:02:46

The state of pharmaceuticals: Bristol-Myers Squibb's plan to buy RayzeBio

0:00:57

The Secrets of Bristol-Myers Squibb's Surprising Past!

0:03:51

The Cell Therapy Process (BMS Cell Therapy Manufacturing Tour)

0:00:36

Bristol-Myers Squibb Company Commercial

0:02:33

How Bristol Myers Squibb games the patent system

0:01:32

Bristol-Myers Squibb 'Native Ad' at the StandUp2Cancer Telethon

0:14:20

Bristol Myers Squibb Aktie // Jetzt noch aufspringen, bevor der Zug weg ist?

0:02:32

Bristol Myers Squibb, the renowned US based global drug maker, has made headlines in India

0:10:09

Bristol Myers Squibb - SOTYKTU™ for Treatment of Moderate-to-Severe Plaque Psoriasis

0:03:13

Bristol Myers Squibb | Patient Stories: Meet Latarsha